Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	282.13	281.97	435.9	232.77	559.99	162.17
Short-Term Investments	868.21	568.77	753.98	845.37	405.65	137.5
Cash & Short-Term Investments	1,150	850.74	1,190	1,078	965.65	299.67
Cash Growth	14.10%	-28.50%	10.36%	11.65%	222.24%	226.27%
Receivables	-	-	-	-	300	-
Prepaid Expenses	25.13	27.41	21.17	14.76	7.36	8.65
Total Current Assets	1,175	878.15	1,211	1,093	1,273	308.32
Property, Plant & Equipment	208.39	216.28	237.81	234.13	186.98	125.37
Other Long-Term Assets	7.3	9.4	10.87	14.69	14.47	17.98
Total Assets	1,391	1,104	1,460	1,342	1,474	451.68
Accounts Payable	10.56	3.87	1.62	9.03	7.47	6.31
Accrued Expenses	31.8	36.13	35.05	30.72	56.87	11.96
Current Portion of Leases	12.95	13.47	12.78	12.23	9.83	6.34
Current Unearned Revenue	105.82	108.86	68.71	135.97	86.27	0.02
Other Current Liabilities	13	19.74	87.42	35.64	53	77.7
Total Current Liabilities	174.13	182.07	205.57	223.6	213.44	102.34
Long-Term Leases	141.85	147.96	159.91	168.63	137.82	101.31
Long-Term Unearned Revenue	20.32	33.22	109.89	202.18	262.3	0.39
Other Long-Term Liabilities	8.04	7.04	3.02	13.84	34.16	2.08
Total Liabilities	344.34	370.28	478.39	608.24	647.72	206.12
Common Stock	1.01	0.84	0.82	0.71	0.68	0.57
Additional Paid-In Capital	2,824	2,299	2,170	1,793	1,594	642.63
Retained Earnings	-1,778	-1,567	-1,190	-1,057	-768.27	-397.64
Comprehensive Income & Other	0.01	0.68	0.6	-2.43	-0.05	-0.01
Total Common Equity	1,047	733.55	981.33	733.47	826.74	245.56
Shareholders' Equity	1,047	733.55	981.33	733.47	826.74	245.56
Total Liabilities & Equity	1,391	1,104	1,460	1,342	1,474	451.68
Total Debt	154.8	161.43	172.69	180.86	147.64	107.64
Net Cash (Debt)	995.53	689.32	1,017	897.28	818	192.03
Net Cash Growth	18.10%	-32.23%	13.36%	9.69%	325.98%	216.82%
Net Cash Per Share	11.21	8.37	13.18	12.82	12.74	4.11
Filing Date Shares Outstanding	98.28	81.11	78.73	70.7	67.6	61.14
Total Common Shares Outstanding	97.87	81.06	78.71	69.58	67.26	55.98
Working Capital	1,001	696.08	1,005	869.3	1,060	205.98
Book Value Per Share	10.70	9.05	12.47	10.54	12.29	4.39
Tangible Book Value	1,047	733.55	981.33	733.47	826.74	245.56
Tangible Book Value Per Share	10.70	9.05	12.47	10.54	12.29	4.39
Machinery	82.77	79.79	69.67	54.79	35.23	18.83
Construction In Progress	7.52	2.53	5.28	5.2	7.35	15.88
Leasehold Improvements	101.71	101.2	100.19	85.8	57.76	12.71

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q